Atlas Trials

Rivastigmine Study in Adolescents With Down Syndrome

Clinical trial NCT01084135 · COMPLETED

Trial details

NCT number
NCT01084135
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Down Syndrome
Start date
2009-11-01
Primary completion
2014-02-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.